Iwasaku Masahiro 岩破將博

… Alternative Names

IWASAKU Masahiro 岩破將博

Less

Researcher Number	30849849
Other IDs
Affiliation (Current)	2026: 京都府立医科大学, 大学院医学研究科, 講師
Affiliation (based on the past Project Information) *help	2026: 京都府立医科大学, 医学(系)研究科(研究院), 助教 2023 – 2024: 京都府立医科大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Basic Section 58010:Medical management and medical sociology-related / Basic Section 58030:Hygiene and public health-related: excluding laboratory approach
Keywords	Principal Investigator NDB / 療養実態 / 肺癌 / データベース / ペイシェントジャーニー

Research Projects
(2 results)
Research Products
(14 results)

がんゲノム医療普及を阻む「真のボトルネック」の多角的解明Principal Investigator
- Principal Investigator
  
  岩破將博
- Project Period (FY)
  2026 – 2029
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 58010:Medical management and medical sociology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Research with approaching the actual care for lung cancer patients from a novel perspective and to elucidate the challenges in medical care.Principal Investigator
- Principal Investigator
  
  IWASAKU Masahiro
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 58030:Hygiene and public health-related: excluding laboratory approach
- Research Institution
  Kyoto Prefectural University of Medicine

All 2025 2024 2023

All Journal Article Presentation Book

[Book] 肺癌治療の新時代治療ゲノム医療2023
- Author(s)
  岩破　將博
- Total Pages
  6
- Publisher
  大道学館出版部
- Data Source
  KAKENHI-PROJECT-23K16334
[Journal Article] Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of >= 50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy2025
- Author(s)
  Kataoka N, Katayama Y, Yamada T, Morimoto K, Takeda T, Okada A, Iwasaku M, et al.
- Journal Title
  
  Oncoimmunology .
  
  Volume: 14 Issue: 1 Pages: 2442116-2442116
- DOI
  10.1080/2162402x.2024.2442116
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K16334
[Journal Article] Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy2024
- Author(s)
  Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T, Tsuyuguchi K, Iwasaku M, et al.
- Journal Title
  
  Thorac Cancer .
  
  Volume: 15 Issue: 26 Pages: 1882-1888
- DOI
  10.1111/1759-7714.15416
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K16334
[Journal Article] Patients’ trajectory with lung cancer from treatment initiation to end-of-life: A retrospective cohort study using Claims Data in japan.2024
- Author(s)
  Ogura Y, Iwasaku M, Ishida M, Katayama Y, Nishioka N, Morimoto K, et al.
- Journal Title
  
  Cancer Control.
  
  Volume: 31
- DOI
  10.1177/10732748241305234
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K16334
[Journal Article] Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non‐small cell lung cancer2024
- Author(s)
  Ishida Masaki、Iwasaku Masahiro、Doi Toshifumi、Ishikawa Takeshi、Tachibana Yusuke、Sawada Ryo、Ogura Yuri、Kawachi Hayato、Katayama Yuki、Nishioka Naoya、Morimoto Kenji、Tokuda Shinsaku、Yamada Tadaaki、Takayama Koichi
- Journal Title
  
  Cancer Science
  
  Volume: 00 Issue: 5 Pages: 1-9
- DOI
  10.1111/cas.16130
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K16334
[Journal Article] Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non?small‐cell lung cancer: A multicenter, Phase <scp>II</scp> trial2023
- Author(s)
  Iwasaku Masahiro、Uchino Junji、Chibana Kenji、Tanzawa Shigeru、Yamada Takahiro、Tobino Kazunori、Uchida Yasuki、Kijima Takashi、Nakatomi Katsumi、Izumi Miiru、Tamiya Nobuyo、Kimura Hideharu、Fujita Masaki、Honda Ryoichi、Takumi Chieko、Yamada Tadaaki、Kaneko Yoshiko、Kiyomi Fumiaki、Takayama Koichi
- Journal Title
  
  Cancer Medicine
  
  Volume: 12 Issue: 14 Pages: 15117-15127
- DOI
  10.1002/cam4.6184
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] 化学療法を施行した肺がん患者のdays at home - 3次治療以降を行うか否か2025
- Author(s)
  小倉　由莉、岩破　將博
- Organizer
  日本臨床腫瘍学会総会
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] BRCA1/2検査の全国的な普及状況と地域差の検討2025
- Author(s)
  岩破　將博
- Organizer
  日本臨床腫瘍学会総会
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] がんゲノムプロファイリング検査の全国的な普及状況と地域差の検討2025
- Author(s)
  岩破　將博
- Organizer
  日本臨床腫瘍学会総会
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] マイクロサテライト不安定(MSI)検査の検査数推移と内訳、地域差の検討2025
- Author(s)
  岩破　將博
- Organizer
  日本臨床腫瘍学会総会
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] RET T754K変異によるセルペルカチニブ耐性が示唆されたKIF5B-RET融合遺伝子の一例2024
- Author(s)
  岩破　將博、髙山浩一ほか
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] Real-world data on next-generation sequencing using comprehensive genomic profiling assays for detecting driver oncogenes in advanced non-small cell lung cancer: Analysis with the National Database of Japan2023
- Author(s)
  石田　真樹、岩破　將博、髙山浩一ほか
- Organizer
  ESMO 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] レセプトデータを用いた京都府における肺癌患者の治療状況と療養場所についての検討2023
- Author(s)
  小倉　由莉、岩破　將博、高山　浩一ほか
- Organizer
  第120回日本内科学会講演会
- Data Source
  KAKENHI-PROJECT-23K16334
[Presentation] がん遺伝子パネル検査によりドライバー遺伝子変異を検出した非小細胞肺癌患者の検討2023
- Author(s)
  石田　真樹、岩破　將博、髙山浩一ほか
- Organizer
  第64回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-23K16334

Iwasaku Masahiro 岩破 將博

IWASAKU Masahiro 岩破 將博

Research Projects

Research Products

がんゲノム医療 普及を阻む「真のボトルネック」の多角的解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research with approaching the actual care for lung cancer patients from a novel perspective and to elucidate the challenges in medical care.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Book] 肺癌治療の新時代 治療 ゲノム医療2023

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of >= 50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy2025

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Patients’ trajectory with lung cancer from treatment initiation to end-of-life: A retrospective cohort study using Claims Data in japan.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non‐small cell lung cancer2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non?small‐cell lung cancer: A multicenter, Phase <scp>II</scp> trial2023

Author(s)

Journal Title

DOI

Data Source

[Presentation] 化学療法を施行した肺がん患者のdays at home - 3次治療以降を行うか否か2025

Author(s)

Organizer

Data Source

[Presentation] BRCA1/2検査の全国的な普及状況と地域差の検討2025

Author(s)

Organizer

Data Source

[Presentation] がんゲノムプロファイリング検査の全国的な普及状況と地域差の検討2025

Author(s)

Organizer

Data Source

[Presentation] マイクロサテライト不安定(MSI)検査の検査数推移と内訳、地域差の検討2025

Author(s)

Organizer

Data Source

[Presentation] RET T754K変異によるセルペルカチニブ耐性が示唆されたKIF5B-RET融合遺伝子の一例2024

Author(s)

Organizer

Data Source

[Presentation] Real-world data on next-generation sequencing using comprehensive genomic profiling assays for detecting driver oncogenes in advanced non-small cell lung cancer: Analysis with the National Database of Japan2023

Author(s)

Organizer

Data Source

[Presentation] レセプトデータを用いた京都府における肺癌患者の治療状況と療養場所についての検討2023

Author(s)

Organizer

Data Source

[Presentation] がん遺伝子パネル検査によりドライバー遺伝子変異を検出した非小細胞肺癌患者の検討2023

Author(s)

Organizer

Data Source

Iwasaku Masahiro 岩破將博

IWASAKU Masahiro 岩破將博

がんゲノム医療普及を阻む「真のボトルネック」の多角的解明Principal Investigator

[Book] 肺癌治療の新時代治療ゲノム医療2023